OptimizeRx Corporation (NASDAQ:OPRX) Q2 2023 Earnings Call Transcript August 14, 2023
OptimizeRx Corporation misses on earnings expectations. Reported EPS is $-0.01 EPS, expectations were $0.02.
Operator: Good afternoon, everyone. And thank you for joining OptimizeRx’s Second Quarter Fiscal 2023 Earnings Discussion. With us today is the Chief Executive Officer of OptimizeRx, William Febbo. He is joined by company Chief Financial Officer, Ed Stelmakh; Chief Commercial Officer, Steve...
